AstraZeneca's Crestor May Harm Kidneys
353921
Twenty-nine patients who took  AstraZeneca Plc's AZN.L AZN.N anti-cholesterol drug Crestor  have developed kidney damage, a U.S. consumer group said on  Friday as it called again for a ban on the medicine.
169281
Study confirmed concerns that the drug significantly raises the risk of heart attack and stroke.
32044
High doses of Zocor provide no benefits in preventing new problems in heart attack patients: study. MUNICH  - Merck&#39;s anti-cholesterol drug Zocor suffered a setback after a major study found high
113293
AstraZeneca was dealt a blow yesterday when an official from the US&#39;s drugs watchdog questioned whether one of its key products ought to be sold in the world&#39;s largest pharmaceuticals market.
191874
Shares in AstraZeneca Plc fell as much as 10 percent on Friday after regulators in the United States and Europe raised safety concerns about the Anglo-Swedish drug maker&#39;s anti-cholesterol treatment Crestor.
362336
By Thomas Ginsberg, The Philadelphia Inquirer  Dec. 19--Wyeth Pharmaceuticals said today that the FDA has agreed to conduct a fast-track review of the company's new kidney cancer-fighting drug, Torisel.
574773
A newspaper advertisement for AstraZeneca Plc's cholesterol drug Crestor that touts patient safety is misleading and should no longer be published, regulators warned in a letter released Wednesday.
425955
DRUGS group AstraZeneca today suffered a massive setback after tests showed its blockbuster Iressa cancer treatment did not allow patients to live longer.
588963
Bayer AG and Onyx Pharmaceutical Inc.'s  key cancer drug Nexavar significantly raises the risk of high  blood pressure, U.S. researchers said on Tuesday.
182075
AstraZeneca Plc. said on Wednesday a new study in Japan showed a higher rate of a potentially fatal side effect in patients taking its lung cancer pill Iressa than that demonstrated in an earlier analysis.
569835
The F.D.A. said that it would consider whether to remove Iressa, a product from AstraZeneca, from the market after the drug failed to prolong the lives of people in a clinical trial.
149001
AstraZeneca today that CRESTORâ¢ (rosuvastatin), its statin indicated for the treatment of dislipidaemia, has reached the significant milestone of 10 million prescriptions worldwide.
321200
The Food and Drug Administration warned consumers not to buy or use Actra-Rx or Yilishen because the supplements contain an ingredient that could lower blood pressure to unsafe levels.
638746
Kidney dialysis patients covered by Medicare are receiving escalating doses of an expensive anti-anemia drug, despite growing evidence that aggressive treatment raises the risk of fatal heart attacks and strokes.
583059
LONDON, October 6  - AstraZeneca (AZN.ISE) has delayed the regulatory approval filing target for its diabetes drug, Galida, from 2006 to 2007, while admitting that its anti-blood clotting drug, Exanta, was unlikely to receive the US
726448
AstraZeneca Plc&#39;s cholesterol-lowering drug Crestor performed better than Pfizer Inc&#39;s Lipitor in an AstraZeneca-funded study of patients with metabolic syndrome, according to results released on Monday.
257852
WASHINGTON Oct 29, 2004 - Consumer advocate Dr. Sidney Wolfe renewed his effort Friday to get the anti-cholesterol drug Crestor removed from sale.